Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
A Hamas leader has threatened to not move forward with the Gaza ceasefire unless Israel faces more pressure to open a key ...
In a stunning decision that defies all expert advice and scientific evidence, the influential group that shapes U.S. vaccine policy will no longer recommend that all infants receive the hepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results